Cargando…

Fatal toxic effects related to EGFR tyrosine kinase inhibitors based on 53 cohorts with 9,569 participants

BACKGROUND: To estimate the incidence and susceptible factors of fatal toxic effects related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). METHODS: PubMed and Embase were thoroughly searched for clinical trials based on the following terms and corresponding Medical Subj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xianhe, Wang, Xuewen, Wu, Sumei, Yang, Haitao, Liu, Junjin, Chen, Huijuan, Ding, Yin, Ling, Liting, Lin, Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475571/ https://www.ncbi.nlm.nih.gov/pubmed/32944317 http://dx.doi.org/10.21037/jtd-19-4000A

Ejemplares similares

SAT-569 Management of Severe Gestational Hypertriglyceridemia
por: Borja, Anne, et al.
Publicado: (2020)

Novel EGFR-TK Inhibitor EKB-569 Inhibits Hepatocellular Carcinoma Cell Proliferation by AKT and MAPK Pathways
por: Kim, Heesue, et al.
Publicado: (2011)

Tumor suppressive role of miR-569 in lung cancer
por: Zheng, Yi Ping, et al.
Publicado: (2018)

SUN-569 Thyroid Associated Orbitopathy (TAO): An Unusual Presentation
por: Costa, Cláudia, et al.
Publicado: (2019)

569 Burn Registries State of Affairs: A Scoping Review
por: Gus, Eduardo I, et al.
Publicado: (2022)

Laparoscopic Cholecystectomy Performed by Residents: A Retrospective Study on 569 Patients
por: Pariani, Dario, et al.
Publicado: (2014)

Correction to Lancet Child Adolesc Health 2018; 2: 569–81
Publicado: (2019)

SUN-569 The Normalization of Sleep Duratioin as a Factor of Glyhemoglobin Reducing
por: Dzherieva, Irina, et al.
Publicado: (2020)

569. Characterization of COVID-19 Vaccine Breakthrough Infections in Metropolitan Detroit
por: sturla, Nicholas, et al.
Publicado: (2021)

Predictive value of positron emission tomography for the prognosis of molecularly targeted therapy in solid tumors
por: Xie, Xianhe, et al.
Publicado: (2018)

Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
por: Jung, Sangyong, et al.
Publicado: (2021)

Irreversible EGFR Inhibitor EKB-569 Targets Low-LET γ-Radiation-Triggered Rel Orchestration and Potentiates Cell Death in Squamous Cell Carcinoma
por: Aravindan, Natarajan, et al.
Publicado: (2011)

Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management
por: Abdullah, Shaad E., et al.
Publicado: (2012)

569 Prevalence of Skin Reactivity to Antigen Mus Musculus in Patients with Respiratory Allergy
por: Caballero, Chrystopherson
Publicado: (2012)

FRI569 A Therapeutic Dilemma: Spontaneous Oscillating Graves' Disease And Hypothyroidism
por: Suravajjala, Devi, et al.
Publicado: (2023)

569. Utility of Repeat Molecular Diagnostic Testing in the Laboratory Diagnosis of Pulmonary Tuberculosis
por: Chia, Jonathan
Publicado: (2023)

Potato consumption is associated with total and cause-specific mortality: a population-based cohort study and pooling of prospective studies with 98,569 participants
por: Mazidi, Mohsen, et al.
Publicado: (2020)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
por: Huang, Lihua, et al.
Publicado: (2015)

Blockade of AXL activation overcomes acquired resistance to EGFR tyrosine kinase inhibition in non-small cell lung cancer
por: Wang, Feng, et al.
Publicado: (2019)

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience
por: Yu, Xiangyang, et al.
Publicado: (2018)

Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
por: Mishani, Eyal, et al.
Publicado: (2008)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
por: Makhlin, Igor, et al.
Publicado: (2019)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
por: Suda, Kenichi, et al.
Publicado: (2021)

Identification of novel methylated DNA marker ZNF569 for head and neck squamous cell carcinoma
por: Liu, Xiangzhen, et al.
Publicado: (2019)

569. Pre-retained: Early Intervention for HIV Patients at High Risk of Becoming Un-retained
por: Abrams-Downey, Alexandra, et al.
Publicado: (2018)

SAT-569 Nuclear TGF-β1 Expression Identifies More Aggressive Thyroid Tumors
por: Peres, Karina, et al.
Publicado: (2019)

569. Evaluation of a Povidone-Iodine Preparation for Nasal Decolonization of Methicillin-Resistant Staphylococcus aureus
por: Abou Ghaddara, Hussein, et al.
Publicado: (2019)

569. A Multidisciplinary Approach to the Pre-evaluation Process of Pediatric Solid Organ Transplant Patients
por: Toia, Jacquie, et al.
Publicado: (2020)

microRNA-569 inhibits tumor metastasis in pancreatic cancer by directly targeting NUSAP1
por: Guo, Xiaohui, et al.
Publicado: (2022)

Epidemiological and Clinical Characteristics of 5,569 Pediatric Burns in Central China From 2013 to 2019
por: Han, Dawei, et al.
Publicado: (2022)

A Novel DUF569 Gene Is a Positive Regulator of the Drought Stress Response in Arabidopsis
por: Nabi, Rizwana Begum Syed, et al.
Publicado: (2021)

THU569 Steroid Receptor Coactivator 3 Is Required To Prevent Early Pregnancy Loss In The Mouse
por: Kumar Maurya, Vineet, et al.
Publicado: (2023)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
por: Xu, Haiyuan, et al.
Publicado: (2019)

Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
por: Amelia, Tasia, et al.
Publicado: (2022)

Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients
por: Wan, Luying, et al.
Publicado: (2022)

AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma
por: Bao, Jiaqi, et al.
Publicado: (2022)

Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases
por: Luo, Shuimei, et al.
Publicado: (2015)

Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer
por: Annunziata, Maria Carmela, et al.
Publicado: (2019)

SAT569 Papillary Thyroid Carcinoma With Renal Metastasis Treated With Radioactive Iodine: A Case Report
por: Apa-Ap, Archimedes Almasol, et al.
Publicado: (2023)

Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors
por: Baldacci, Simon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cho7cjqnmggvc53fvsh4hllkhq